GlassScriptPhysician profile
Abigayle Ryan Neel
NPI 1225790280
$1,641.73
in general payments reported to CMS, 2019-2025
16 companies · $808 in 2025
The $808 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $275 · 2023: $41.74 · 2024: $392 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.84 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $505.58 | 2021-2025 | Dupixent |
| Genzyme Corporation | $334.89 | 2023-2025 | |
| Inspire Medical Systems, INC. | $241.04 | 2024-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.64 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $102.65 | 2022 | |
| Optinose US, INC. | $95.73 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2025 | |
| Paratek Pharmaceuticals, INC. | $32.12 | 2025 | Xhance |
| Hikma Pharmaceuticals USA | $28.24 | 2024-2025 | Ryaltris |
| Aimmune Therapeutics, INC. | $24.60 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.10 | 2023 | Glassia |
| Amgen INC. | $19.94 | 2025 | Tezspire |
| Smith+Nephew, INC. | $19.83 | 2025 | Tula, Halo |
| Csl Behring | $18.72 | 2022 | |
| Mylan Specialty L.P. | $17.29 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $14.37 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigayle Neel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.